Page last updated: 2024-09-03

candoxatrilat and vasoactive intestinal peptide

candoxatrilat has been researched along with vasoactive intestinal peptide in 1 studies

Compound Research Comparison

Studies
(candoxatrilat)
Trials
(candoxatrilat)
Recent Studies (post-2010)
(candoxatrilat)
Studies
(vasoactive intestinal peptide)
Trials
(vasoactive intestinal peptide)
Recent Studies (post-2010) (vasoactive intestinal peptide)
4610110,8731231,221

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cleland, JG; Good, JM; Jackson, N; Oakley, CM; Peters, M; Wilkins, M1

Trials

1 trial(s) available for candoxatrilat and vasoactive intestinal peptide

ArticleYear
Renal response to candoxatrilat in patients with heart failure.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:6

    Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cross-Over Studies; Cyclic GMP; Cyclohexanecarboxylic Acids; Diuresis; Double-Blind Method; Drug Administration Schedule; Electrolytes; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neprilysin; Renal Circulation; Sodium; Urine; Vasoactive Intestinal Peptide

1995